jRCT2031220474招募中不适用
A Phase I Clinical Study of NS-025 in Healthy Subjects
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 122
- 主要终点
- -
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized Controlled Trial
- 干预模型
- Parallel Assignment
- 主要目的
- Basic Science
- 盲法
- Double Blind
入排标准
- 年龄范围
- 20age old over 至 65age old not（—）
- 性别
- All
入选标准
- •Provided written informed consent
- •Japanese male subjects
- •White male subjects
- •Japanese female subjects of non-childbearing potential
排除标准
- •Subjects with a history of surgery which may have an impact on drug absorption
- •Subjects with a history of allergy or hypersensitivity to drugs or foods
- •Subjects who collected 200 mL or more of whole blood or component blood within 2 weeks before administration of the study drug
- •Subjects who have received other investigational products within 16 weeks (112 days) prior to the first investigational product administration
结局指标
主要结局
-
Pharmacokinetic, Safety, Tolerability
次要结局
未报告次要终点
研究者
相似试验
招募中
1 期
A Phase I Clinical Study of NS-025 in Healthy SubjectsJPRN-jRCT2031220474Higashioka Masaya122
进行中（未招募）
不适用
Clinical Pharmacology Study of NS-025 in Healthy male subjects (Phase I Study)
(Drug-Drug Interaction Study with triazolam) (NS025-P1-02)jRCT2031240632Nippon Shinyaku Co., Ltd.25
招募中
1 期
A phase 1 study in patients with Fukuyama-type congenital muscular dystrophyFukuyama-type congenital muscular dystrophyJPRN-jRCT2031210252Toda Tatsushi12
未知
1 期
Phase 1/2 study of NS-065/NCNP-01 in patients with Duchenne muscular dystrophyDuchenne muscular dystrophyJPRN-jRCT2080223236IPPON SHINYAKU CO., LTD.16
已完成
1 期
Clinical Pharmacology Study of NS-580 in Healthy female subjects (Phase I Study)endometriosisJPRN-jRCT2071220011Higashioka Masaya64